• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lyka Labs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 677.0
  • ISIN : INE933A01014
100.41 0 (0.45%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    99.00

  • Today’s High

    104.00

  • Open

    99.85

  • Perv Close

    99.96

  • 52W Low

    97.90

  • 52W High

    176.59

Key Indicators

  • P/E(TTM)

    67.75

  • Mar.Cap (₹Cr.)

    358.36

  • Div & Yield %

    0.00

  • Book Value(₹)

    36.64

  • Debt-Equity Ratio

    0.45

  • AGM Date

    28-Mar-2025

  • EPS

    1.49

  • P/E Ratio

    67.75

Financials Ratios

  • Debt-Equity Ratio

    1.14

  • Mar.Cap (₹Cr.)

    358.36

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    35.69

  • BV (₹)

    36.60

  • Sales( ₹ in Cr.)

    106.40

  • NP (in Cr.)

    -2.31

  • NP Var(%)

    63.0

  • Div%

    0.0

  • CPS (₹)

    2.80

  • EPS (₹)

    -0.60

  • Traded Value (₹ in Lakhs)

    360.29

  • 52 Week High

    176.59

  • 52 Week Low

    97.90

  • Price BSE

    101.0

  • Price NSE

    100.00

  • Market Capital( in Cr.)

    360.29

  • P/C Ratio

    36.10

  • P/E Ratio

    -156.20

  • Price Vs.BV

    -0.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 106.40 80.59 164.35 62.26 40.74 41.18
Excise Duty 101.50 76.31 154.77 44.73 36.41 37.17
Net Sales 106.40 80.59 164.35 62.26 40.74 41.18
Other Income 1.65 3.45 2.72 2.21 2.60 2.58
Stock Adjustments -0.11 -0.11 0.00 0.00 -0.11 0.00
Total Income 108.04 84.04 167.07 64.47 43.34 43.76
EXPENDITURE :
Raw Materials 101.50 76.31 154.77 44.73 36.41 37.17
Power & Fuel Cost 101.50 76.31 154.77 44.73 36.41 37.17
Employee Cost 26.01 17.48 16.22 13.03 11.71 9.99
Other Manufacturing Expenses 1.20 0.89 1.60 0.48 1.88 0.53
Selling & Administrative Expenses 15.23 11.18 12.04 5.63 5.43 4.13
Miscellaneous Expenses 1.20 0.89 1.60 0.48 1.88 0.53
Less : Pre-operative Expenses Capitalised :
Total Expenditure 108.92 90.08 102.16 81.44 70.74 50.33
Operating Profit 6.44 6.38 6.13 5.18 3.92 3.27
Interest 4.80 11.57 19.92 25.55 19.01 5.73
Gross Profit -0.93 -13.21 60.24 -18.40 -55.15 -7.10
Depreciation 12.29 13.52 15.39 8.05 7.77 4.44
Profit Before Tax -0.93 -13.21 60.24 -18.40 -55.15 -7.10
Tax 1.60 0.21 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.26 -0.13 20.34 -3.94 0.24 -8.83
Reported Net Profit -2.27 -13.29 39.90 -14.46 -55.39 1.73
Extraordinary Items -0.93 -13.21 60.24 -18.40 -55.15 -7.10
Adjusted Net Profit -2.27 -13.29 39.90 -14.46 -55.39 1.73
Adjustment below Net Profit -0.11 -0.11 0.00 0.00 -0.11 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -2.27 -13.29 39.90 -14.46 -55.39 1.73
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.72 -4.65 13.90 -5.04 -19.48 0.62
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    58.10%

  • Public Share Holding

    41.90%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 15,644,923 43.84 15,644,923 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,092,586 14.27 5,092,586 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 20,737,509 58.10 20,737,509 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 700 0.00 50 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 55,078 0.15 55,078 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 101,000 0.28 100,000 2
Mutual Funds / UTI 3,400 0.01 0 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 132,651 0.37 132,651 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 292,829 0.82 287,779 15
2] Non Institution
Bodies Corporate 1,749,300 4.90 1,748,438 176
Clearing Members 1,295 0.00 1,295 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 500 0.00 500 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 410,804 1.15 405,847 259
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 801,909 2.25 801,801 617
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,212,634 9.00 3,212,634 58
Individuals holding nominal share capital up to Rs. 1 lakh 8,254,390 23.13 8,054,151 27,943
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,500 0.00 1,500 1
Others 0 0.00 0 0
Sub Total 14,659,662 41.08 14,452,996 29,074
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 35,690,000 100.00 35,478,284 29,099

Company Background

Lyka Labs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Lyka Labs Ltd
  • BSE Code : 677.0
  • ISIN : INE933A01014

  • Incorporation Year

    1976

  • Registered Office

    4801/B & 4802/A
    GIDC Industrial Estate, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-02646-221422/220549

  • FAX

    91-02646-250692

  • Chairman

    Babulal Jain

  • Managing Director

    KUNAL NARENDRA GANDHI

  • Company Secretary

    Shekhar R Singh

  • Auditor

    D Kothary & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    C-101 247 Park ,
    L B S Marg ,Vikhroli West
    Mumbai - Mumbai - 400083

Lyka Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lyka Labs 100.95 108.04 106.40 68.21 0.00
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92